Literature DB >> 23035064

Assessment of cortical and striatal involvement in 523 Huntington disease brains.

Tiffany C Hadzi1, Audrey E Hendricks, Jeanne C Latourelle, Kathryn L Lunetta, L Adrienne Cupples, Tammy Gillis, Jayalakshmi Srinidhi Mysore, James F Gusella, Marcy E MacDonald, Richard H Myers, Jean-Paul Vonsattel.   

Abstract

OBJECTIVE: To evaluate the relationship of striatal involvement in Huntington disease (HD) to involvement in other brain regions, CAG repeat size, onset age, and other factors.
METHODS: We examined patterns of neuropathologic involvement in 664 HD brains submitted to the Harvard Brain Tissue Resource Center. Brains with concomitant Alzheimer or Parkinson changes (n = 82), more than 20% missing data (n = 46), incomplete sample submission (n = 12), or CAG repeat less than 36 (n = 1) were excluded, leaving 523 cases. Standardized ratings from 0 (absent) to 4 (severe) of gross and microscopic involvement were performed for 50 regions. Cluster analysis reduced the data to 2 main measures of involvement: striatal and cortical.
RESULTS: The clusters were correlated with each other (r = 0.42) and with disease duration (striatal: r = 0.35; cortical: r = 0.31). The striatal cluster was correlated with HD repeat size (r = 0.50). The cortical cluster showed a stronger correlation with decreased brain weight (r = -0.52) than the striatal cluster (r = -0.33). The striatal cluster was correlated with younger death age (r = -0.31) and onset age (r = -0.46) while the cortical cluster was not (r = 0.09, r = -0.04, respectively).
CONCLUSIONS: The 2 brain clusters had different relationships to the HD CAG repeat size, onset age, and brain weight, suggesting that neuropathologic involvement does not proceed in a strictly coupled fashion. The pattern and extent of involvement varies substantially from one brain to the next. These results suggest that regional involvement in HD brain is modified by factors which, if identified, may lend insight into novel routes to therapeutics.

Entities:  

Mesh:

Year:  2012        PMID: 23035064      PMCID: PMC3468776          DOI: 10.1212/WNL.0b013e31826e9a5d

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  20 in total

1.  The brain in Huntington's chorea.

Authors:  E D Bird
Journal:  Psychol Med       Date:  1978-08       Impact factor: 7.723

2.  Degeneration of pyramidal projection neurons in Huntington's disease cortex.

Authors:  M Cudkowicz; N W Kowall
Journal:  Ann Neurol       Date:  1990-02       Impact factor: 10.422

3.  Clinical and neuropathologic assessment of severity in Huntington's disease.

Authors:  R H Myers; J P Vonsattel; T J Stevens; L A Cupples; E P Richardson; J B Martin; E D Bird
Journal:  Neurology       Date:  1988-03       Impact factor: 9.910

4.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Authors: 
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Longitudinal change in regional brain volumes in prodromal Huntington disease.

Authors:  Elizabeth H Aylward; Peggy C Nopoulos; Christopher A Ross; Douglas R Langbehn; Ronald K Pierson; James A Mills; Hans J Johnson; Vincent A Magnotta; Andrew R Juhl; Jane S Paulsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-09-30       Impact factor: 10.154

6.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

7.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

8.  Morphometric analysis of the prefrontal cortex in Huntington's disease.

Authors:  A Sotrel; P A Paskevich; D K Kiely; E D Bird; R S Williams; R H Myers
Journal:  Neurology       Date:  1991-07       Impact factor: 9.910

9.  Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.

Authors:  S M de la Monte; J P Vonsattel; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1988-09       Impact factor: 3.685

10.  A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study.

Authors:  Jian-Liang Li; Michael R Hayden; Elisabeth W Almqvist; Ryan R Brinkman; Alexandra Durr; Catherine Dodé; Patrick J Morrison; Oksana Suchowersky; Christopher A Ross; Russell L Margolis; Adam Rosenblatt; Estrella Gómez-Tortosa; David Mayo Cabrero; Andrea Novelletto; Marina Frontali; Martha Nance; Ronald J A Trent; Elizabeth McCusker; Randi Jones; Jane S Paulsen; Madeline Harrison; Andrea Zanko; Ruth K Abramson; Ana L Russ; Beth Knowlton; Luc Djoussé; Jayalakshmi S Mysore; Suzanne Tariot; Michael F Gusella; Vanessa C Wheeler; Larry D Atwood; L Adrienne Cupples; Marie Saint-Hilaire; Jang-Ho J Cha; Steven M Hersch; Walter J Koroshetz; James F Gusella; Marcy E MacDonald; Richard H Myers
Journal:  Am J Hum Genet       Date:  2003-08-01       Impact factor: 11.025

View more
  24 in total

1.  Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.

Authors:  Robert Christian Wolf; Philipp Arthur Thomann; Fabio Sambataro; Nadine Donata Wolf; Nenad Vasic; G Bernhard Landwehrmeyer; Sigurd Dietrich Süßmuth; Michael Orth
Journal:  J Neurol       Date:  2015-01-28       Impact factor: 4.849

Review 2.  Exploring the role of high-mobility group box 1 (HMGB1) protein in the pathogenesis of Huntington's disease.

Authors:  Efthalia Angelopoulou; Yam Nath Paudel; Christina Piperi
Journal:  J Mol Med (Berl)       Date:  2020-02-08       Impact factor: 4.599

3.  Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: a three-year follow-up study.

Authors:  Omar F F Odish; Annette A van den Berg-Huysmans; Simon J A van den Bogaard; Eve M Dumas; Ellen P Hart; Serge A R B Rombouts; Jeroen van der Grond; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2014-08-19       Impact factor: 5.038

4.  Epigenetic dysregulation of hairy and enhancer of split 4 (HES4) is associated with striatal degeneration in postmortem Huntington brains.

Authors:  Guang Bai; Iris Cheung; Hennady P Shulha; Joana E Coelho; Ping Li; Xianjun Dong; Mira Jakovcevski; Yumei Wang; Anastasia Grigorenko; Yan Jiang; Andrew Hoss; Krupal Patel; Ming Zheng; Evgeny Rogaev; Richard H Myers; Zhiping Weng; Schahram Akbarian; Jiang-Fan Chen
Journal:  Hum Mol Genet       Date:  2014-12-05       Impact factor: 6.150

5.  Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.

Authors:  Andrew G Hoss; Valentina N Lagomarsino; Samuel Frank; Tiffany C Hadzi; Richard H Myers; Jeanne C Latourelle
Journal:  Mov Disord       Date:  2015-11-17       Impact factor: 10.338

6.  Evidence for a Pan-Neurodegenerative Disease Response in Huntington's and Parkinson's Disease Expression Profiles.

Authors:  Adam Labadorf; Seung H Choi; Richard H Myers
Journal:  Front Mol Neurosci       Date:  2018-01-11       Impact factor: 5.639

7.  The Allure of High-Risk Rewards in Huntington's disease.

Authors:  Nelleke C van Wouwe; Kristen E Kanoff; Daniel O Claassen; K Richard Ridderinkhof; Peter Hedera; Madaline B Harrison; Scott A Wylie
Journal:  J Int Neuropsychol Soc       Date:  2015-12-28       Impact factor: 2.892

8.  The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease.

Authors:  Jae Whan Keum; Aram Shin; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Kawther Abu Elneel; Diane Lucente; Tiffany Hadzi; Peter Holmans; Lesley Jones; Michael Orth; Seung Kwak; Marcy E MacDonald; James F Gusella; Jong-Min Lee
Journal:  Am J Hum Genet       Date:  2016-02-04       Impact factor: 11.025

9.  Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.

Authors:  Omar F F Odish; Alexander Leemans; Robert H A M Reijntjes; Simon J A van den Bogaard; Eve M Dumas; Ron Wolterbeek; Chantal M W Tax; Hugo J Kuijf; Koen L Vincken; Jeroen van der Grond; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2015-02-03       Impact factor: 5.038

10.  Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study.

Authors:  Omar F F Odish; Karen Caeyenberghs; Hadi Hosseini; Simon J A van den Bogaard; Raymund A C Roos; Alexander Leemans
Journal:  Neuroimage Clin       Date:  2015-07-31       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.